Srikanth Mahankali
30 works · 3,286 citations · h-index 16
Top works
- Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging
- Effect of Pioglitazone on Abdominal Fat Distribution and Insulin Sensitivity in Type 2 Diabetic Patients
- Improved Glycemic Control and Enhanced Insulin Sensitivity in Type 2 Diabetic Subjects Treated With Pioglitazone
- Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients
- Lie detection by functional magnetic resonance imaging
- Altered hypothalamic function in response to glucose ingestion in obese humans.
- Separate Contribution of Diabetes, Total Fat Mass, and Fat Topography to Glucose Production, Gluconeogenesis, and Glycogenolysis
- High Prevalence of Pineal Cysts in Healthy Adults Demonstrated by High-Resolution, Noncontrast Brain MR Imaging
- Perfusion-weighted imaging of interictal hypoperfusion in temporal lobe epilepsy using FAIR-HASTE: Comparison with H215O PET measurements
- Increased detectability of alpha brain glutamate/glutamine in neonatal hypoxic-ischemic encephalopathy.
- Cerebral hemodynamic response in Chinese (first) and English (second) language processing revealed by event-related functional MRI
- Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in patients with type 2 diabetes
- Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme
- Functional MRI of visual–spatial processing in neurofibromatosis, type I
- In vivo fMRI demonstration of hypothalamic function following intraperitoneal glucose administration in a rat model
- Neural correlates of response inhibition for behavioral regulation in humans assessed by functional magnetic resonance imaging
- Functional Magnetic Resonance Imaging of Phonologic Processing in Neurofibromatosis 1
- Cerebral MR Perfusion Imaging: Principles and Current Applications
- Phase II trial of thalidomide in combination with irinotecan in adults with recurrent glioblastoma multiforme
- Phase II study of the combination of thalidomide and irinotecan in patients with recurrent anaplastic gliomas not on enzyme inducing anticonvulsants